Yang, Y., Zhou, J., Li, X., Zhao, L., Cheng, Y., Lin, Y., . . . Wang, J. (2017). Gefitinib enhances sensitivity of endometrial cancer cells to progestin therapy via dual-specificity phosphatase 1. Oncotarget.
Chicago Style CitationYang, Yuan, et al. "Gefitinib Enhances Sensitivity of Endometrial Cancer Cells to Progestin Therapy Via Dual-specificity Phosphatase 1." Oncotarget 2017.
MLA CitationYang, Yuan, et al. "Gefitinib Enhances Sensitivity of Endometrial Cancer Cells to Progestin Therapy Via Dual-specificity Phosphatase 1." Oncotarget 2017.
Warning: These citations may not always be 100% accurate.